Table 4.
Patient education in AD across HCPs
| Item | GPs (n = 111) | YHPs (n = 25) | Pediatricians (n = 46) | Dermatologists (n = 53) | Pharmacists (n = 42) | Pharmacy assistants (n = 70) |
|---|---|---|---|---|---|---|
| Emollients, n (%) | ||||||
| No instructions | 0 (0) | 0 (0) | 0 (0) | 1 (2) | 0 (0) | 2 (3) |
| Apply if necessary | 2 (2) | 1 (4) | 5 (11) | 1 (2) | 15 (36) | 22 (31) |
| Once or twice dailya | 109 (98) | 18 (72) | 41 (89) | 51 (96) | 26 (62) | 42 (60) |
| Check with prescriberb | – | 6 (24) | – | – | 1 (2) | 2 (3) |
| TCS start instructions, n (%) | ||||||
| No instructions | 0 (0) | 0 (0) | 0 (0) | 1 (2) | 0 (0) | 2 (3) |
| Every other day | 0 (0) | 0 (0) | 0 (0) | 1 (2) | 0 (0) | 0 (0) |
| Maximum of 5 days | 5 (5) | 2 (8) | 0 (0) | 3 (6) | 0 (0) | 0 (0) |
| Once a daya | 32 (29) | 3 (12) | 11 (24) | 30 (57) | 9 (21) | 7 (10) |
| Twice a daya | 74 (67) | 4 (16) | 35 (76) | 18 (34) | 8 (19) | 22 (31) |
| Check with patient | – | 0 (0) | – | – | 18 (43) | 29 (41) |
| Check with prescriberb | – | 16 (64) | – | – | 7 (17) | 8 (11) |
| TCS continuation instructions, n (%) | ||||||
| No instructions | 0 (0) | 1 (4) | 0 (0) | 1 (2) | 0 (0) | 3 (4) |
| 1 week | 18 (16) | 2 (8) | 1 (2) | 2 (4) | 2 (5) | 5 (7) |
| Up to 4 weeks | 70 (63) | 4 (16) | 6 (13) | 19 (36) | 9 (21) | 27 (39) |
| Until eczema is gonea | 23 (21) | 5 (20) | 39 (85) | 31 (59) | 8 (19) | 5 (7) |
| Check with patient | – | 0 (0) | – | – | 20 (48) | 27 (39) |
| Check with prescriberb | – | 13 (52) | – | – | 3 (7) | 1 (1) |
| TCS stop instructions, n (%) | ||||||
| No instructions | 2 (2) | 1 (4) | 0 (0) | 1 (2) | 0 (0) | 2 (3) |
| Stop directly | 27 (24) | 1 (4) | 3 (7) | 1 (2) | 2 (5) | 2 (3) |
| Tapering schemea | 52 (47) | 15 (60) | 43 (94) | 51 (96) | 27 (64) | 53 (76) |
| Check with patient | – | 0 (0) | – | – | 11 (26) | 8 (11) |
| Check with prescriberb | – | 8 (32) | – | – | 2 (5) | 3 (4) |
| TCS application instructions, n (%) | ||||||
| No instructions | 6 (5) | 4 (16) | 1 (2) | 1 (2) | 0 (0) | 2 (3) |
| Thin | 43 (39) | 6 (24) | 4 (9) | 3 (6) | 6 (14) | 11 (16) |
| FTUa | 61 (55) | 9 (36) | 40 (87) | 47 (89) | 36 (86) | 55 (79) |
| Thick | 0 (0) | 0 (0) | 1 (2) | 2 (4) | 0 (0) | 0 (0) |
| Check with prescriberb | – | 6 (24) | – | – | 0 (0) | 0 (0) |
| Estimated duration of applying one tube of 30 grams for a 1-year-old infant with severe AD (BSA 50%), n (%) | ||||||
| 1–2 days | 0 (0) | 0 (0) | 0 (0) | 1 (2) | 0 (0) | 2 (3) |
| 3–5 days | 8 (7) | 0 (0) | 2 (4) | 7 (13) | 2 (5) | 11 (16) |
| 4 weeksa | 44 (40) | 7 (28) | 20 (44) | 27 (51) | 19 (45) | 22 (31) |
| 2 weeks | 42 (38) | 9 (36) | 20 (44) | 15 (28) | 16 (38) | 23 (33) |
| 1 month | 15 (14) | 8 (32) | 3 (7) | 3 (6) | 5 (12) | 5 (7) |
| >2 months | 1 (1) | 1 (4) | 0 (0) | 0 (0) | 0 (0) | 4 (6) |
| Estimated duration of applying one tube of 30 grams for a 14-year-old adolescent with severe AD (BSA 50%), n (%) | ||||||
| 1–2 days | 15 (14) | 4 (16) | 7 (15) | 14 (26) | 8 (19) | 21 (30) |
| 3–5 daysa | 28 (25) | 7 (28) | 20 (44) | 26 (49) | 22 (52) | 16 (23) |
| 1 week | 44 (40) | 2 (8) | 14 (30) | 8 (16) | 5 (12) | 9 (13) |
| 2 weeks | 16 (14) | 10 (40) | 3 (7) | 3 (6) | 5 (12) | 13 (19) |
| 1 month | 5 (5) | 2 (8) | 1 (2) | 1 (2) | 2 (5) | 6 (9) |
| >2 months | 2 (2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (3) |
TCS, topical corticosteroids; TCI, topical calcineurine inhibitor; FTU, fingertip unit.
bCheck with prescriber implies that a YHP, pharmacist, or pharmacy assistant would consult the prescriber before providing any recommendations. In the case of YHPs, treatment may have been prescribed by another physician.